HSIC vs WAY · P/E 24, rev $6.83B vs P/E 27, rev $1.10B
Henry Schein Inc (HSIC) versus Waystar Holding Corp. Common Stock (WAY) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Waystar Holding Corp. Common Stock (WAY) is a health information services company listed on NASDAQ.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported WAY revenue for 2025-12-31 was $1.10B. Net income was $112.1M. Revenue was up 16.5% from 2024-12-31 to 2025-12-31. WAY currently screens at market cap $3.50B and trailing P/E 27.2.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. WAY currently screens at market cap $3.50B and trailing P/E 27.2.
Not investment advice. Open the HSIC and WAY stock pages for the full models.
Not investment advice.